Koers Standard BioTools Inc.
Aandelen
LAB
US34385P1084
Geavanceerde medische apparatuur & technologie
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,565 USD | +0,98% | -1,72% | +16,06% |
Omzet 2024 * | 201 mln. 188 mln. | Omzet 2025 * | 232 mln. 217 mln. | Marktkapitalisatie | 981 mln. 916 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -161 mln. -150 mln. | Nettowinst (verlies) 2025 * | -69 mln. -64,44 mln. | EV/omzet 2024 * | 4,88 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 4,23 x |
K/w-verhouding 2024 * |
-5,91
x | K/w-verhouding 2025 * |
-14,1
x | Werknemers | 537 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 97,94% |
Recentste transcriptie over Standard BioTools Inc.
1 dag | +0,98% | ||
1 week | -1,72% | ||
Lopende maand | -5,35% | ||
1 maand | -5,00% | ||
3 maanden | +9,62% | ||
6 maanden | +17,12% | ||
Lopend jaar | +16,06% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Michael Egholm
CEO | Chief Executive Officer | 61 | 04-04-22 |
Jeffrey Black
DFI | Director of Finance/CFO | 55 | 15-05-23 |
Shane Bowen
CTO | Chief Tech/Sci/R&D Officer | - | 05/01 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 70 | 01-04-22 | |
Fenel Eloi
BRD | Director/Board Member | 66 | 15-03-23 |
Kathy Hibbs
BRD | Director/Board Member | 60 | 05/01 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.01% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
22-04-24 | 2,54 | +0,79% | 2 286 002 |
19-04-24 | 2,52 | -0,79% | 2 753 470 |
18-04-24 | 2,54 | -2,68% | 2 831 907 |
17-04-24 | 2,61 | -3,69% | 3 703 485 |
16-04-24 | 2,71 | -2,17% | 2 672 336 |
uitgestelde koers Nasdaq, 23 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,06% | 971 mln. | |
+8,35% | 209 mld. | |
+9,41% | 175 mld. | |
+11,75% | 131 mld. | |
+19,34% | 99,98 mld. | |
-0,84% | 61,12 mld. | |
+15,08% | 52,34 mld. | |
-2,10% | 46,5 mld. | |
+0,10% | 39,24 mld. | |
+11,50% | 38,47 mld. |